Results 211 to 220 of about 84,496 (265)
Some of the next articles are maybe not open access.

Canine platelet transfusions

Journal of Veterinary Emergency and Critical Care, 2009
AbstractObjective –To review potential platelet storage options, guidelines for administration of platelets, and adverse events associated with platelet transfusions.Data Sources –Data sources included original research publications and scientific reviews.Human Data Synthesis –Transfusion of platelet concentrates (PCs) plays a key role in the ...
Mary Beth, Callan   +2 more
openaire   +2 more sources

Blood Platelets and Platelet Transfusions

Archives of Internal Medicine, 1961
The application of quantitative biological and biochemical methods to the study of the blood platelets has led to revolutionary developments in our understanding of these elusive structures. 1 Until recently platelets were often regarded as non-cellular in nature, although it has long been known that they are of cellular origin.
openaire   +2 more sources

Prophylactic Platelet Transfusion

New England Journal of Medicine, 2013
To the Editor: We recently reported on a trial1 that was similar to the Trial of Prophylactic Platelets (TOPPS) by Stanworth et al. (May 9 issue).2 TOPPS showed that a strategy of prophylactic platelet transfusion, as compared with a strategy of no prophylaxis, was marginally superior in preventing bleeding of World Health Organization (WHO) grade 2 or
Hannes, Wandt   +2 more
openaire   +3 more sources

Platelet transfusion therapy

Journal of Clinical Apheresis, 2001
AbstractThe relative merits of apheresis platelets and platelet concentrates are undergoing debate due to evolving issues of safety, inventory, and cost. The application of photochemical inactivation technology may eliminate any rationale for the use of apheresis platelets rather than pooled platelet concentrates, so that the relative merits of these ...
openaire   +2 more sources

Overview of Platelet Transfusion

Seminars in Hematology, 2010
Most platelet transfusions are given to prevent bleeding in thrombocytopenic patients undergoing chemotherapy for malignancy or hematopoietic stem cell transplant. In stable, uncomplicated patients the risk of bleeding is similar until the platelet count falls to
openaire   +2 more sources

Platelet serology and transfusion

Human Pathology, 1983
Various methods of detecting platelet antibodies have been developed relatively recently. This review describes assays in current use and their application to clinical practice, particularly in the management of alloimmunized recipients of platelet transfusions.
W V, Miller, J A, Harmon
openaire   +2 more sources

Trigger for Platelet Transfusion

Vox Sanguinis, 2000
Background and Objectives:The terms ‘platelet transfusion trigger’ are used in the scientific literature to indicate a value of the platelet count above which prophylactic platelet transfusion is usually not indicated. Most clinicians share the currently prevalent consensus published in several guidelines that a platelet transfusion trigger of 10,000 ...
openaire   +2 more sources

Platelet Transfusion Therapy

Clinics in Laboratory Medicine, 1996
Although platelet transfusion is a vital part of modern hemotherapy, many related issues are unresolved. The most appropriate trigger point of transfusion and the clinical utility of prophylactic transfusion are still debated, but the importance of patient-specific transfusion decisions is clear.
openaire   +2 more sources

Platelet Transfusions in Pediatrics

New England Journal of Medicine, 1957
THE transfusion of fresh human platelets has been shown to be an effective and practical way to control the hemorrhagic episodes in thrombocytopenia.1 Recently a variety of technics have been devised for the preparation of platelet concentrates that permit prompt infusion of therapeutically effective amounts of platelets without the delay or ...
openaire   +2 more sources

Platelet Transfusion Therapy

Hematology/Oncology Clinics of North America, 1990
This article reviews appropriate platelet support of those patients who are chronically thrombocytopenic because of decreased platelet production, including those receiving chemotherapy or radiation treatments and those undergoing bone marrow transplants.
openaire   +3 more sources

Home - About - Disclaimer - Privacy